Clinical-Stage Nuvie Bio Announces Positive Phase 1 Data for Migraine Program
January 8, 2025
Nuvie Bio, a new clinical-stage biopharmaceutical company dedicated to addressing the most pressing unmet medical needs in migraine and related neurological diseases, announced completion of